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Purpose
Gadofosveset is characterized by a lipophilic side chain which leads to a transient, reversible and non-covalent binding to serum albumin 1 . The transient protein interaction increases T1-relaxtivity four to five times compared to standard extracellular gadolinium chelates at 1.5T 2, 3 which is particular beneficial for vascular imaging.
Besides dynamic imaging of the arterial-dominant phase after single bolus injection extended imaging during the steady state of the contrast agent can be performed 4, 5 . Compared to imaging in the first pass, optimal image quality in the steady state theoretically requires longer TR times and lower flip angles. The purpose of this study was the comparison of three optimized pulse sequences for thoracoabdominal contrast-enhanced magnetic-resonance angiography by noise measurements and time-dependent T1-mapping in the steady state after injection of 0.03mmol/kg BW gadofosveset.
Methods and Materials
After IRB approval, 15 healthy volunteers (mean age 31.5 years; range 19-46 years) were included in this prospective, intraindividual comparison study. All exams were performed on a whole-body MR system (MAGNETOM Avanto) at 1.5T. ) were repeated 10, 20, 30 and 40 minutes after the injection of 0.03mmol/kg bodyweight gadofosveset (mean dose 9.7mL; range 7.2-13.4 mL). The injections were followed by a saline flush of 30 mL at the same injection rate (4 mL/s) as the contrast agent. 3D-gradient echo sequences with variable flip angles (TE-1.28ms, TR-3.85, FA-5°/10°/15°/20°/25°/30°, voxel size-1.5×1.2×1.5mm 
Results
At each point of time, VIBE semi and VIBE opt yielded a significant higher SNR (p=0.006-p<0.001) and CNR (p=0.005-p<0.001) in the aorta compared to the 3D-FLASH sequence. Respectively in the inferior vena cava, SNR (p=0.001-p<0.001) and CNR (p=0.001-p<0.001) were significantly higher for both VIBE sequences. No significant differences of SNR and CNR were obtained between VIBE semi and VIBE opt . In the aorta the maximal percentage gain of SNR was 44.2% for the VIBE semi compared to the 3D-FLASH. Over the time, the SNR and CNR decreased in the aorta as well in the inferior vena cava for each sequence. A maximal decrease of SNR was assessed for 3D-FLASH (aorta -69.6%) and a minimal one for VIBE SEMI (aorta -39.9%).
The T1 relaxation time decreased 10 minutes after injection from 1227.4±382.7ms to 141.2±26.9ms in the aorta and from 1192.8±397.7ms to 145.5±25.7ms in the inferior vena cava. At 20 minutes to 50 minutes post injection a constant slow increase was marked in the aorta to 174.5±29.3ms and in the inferior vena cava to 185.5±28.3ms.
Images for this section: 
Conclusion
For MRA in the steady state after a single dose of gadofosveset, VIBE sequences seem superior compared to the 3D-FLASH type. No additional improvements were obtained by theoretically optimized sequence parameters in the VIBE OPT with a longer TR. Gadofosveset provides a sufficient shortening of T1 times for vessel imaging in the steady state. For the MRA a time frame in the steady state 10 to 30 minutes after the injection of a single dose of gadofosveset seems to be appropriate for imaging with a sufficient SNR / CNR and constant longitudinal relaxation time (T1).
